{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:11Z","timestamp":1793332451326,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jcin.2024.03.029","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:38:32Z","timestamp":1717598312000},"page":"1547-1556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions"],"prefix":"10.1016","volume":"17","author":[{"given":"Osamu","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-4079","authenticated-orcid":false,"given":"Shigeo","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-6438","authenticated-orcid":false,"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyab","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Kozuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcin.2024.03.029_bib1","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.029_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.03.029_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.029_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.03.029_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.03.029_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2024.03.029_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-Year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.029_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjcard.2020.05.015","article-title":"Meta-analysis comparing endovascular treatment modalities for femoropopliteal peripheral artery disease","volume":"128","author":"Khan","year":"2020","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2024.03.029_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s42155-022-00308-z","article-title":"Utility of sirolimus coated balloons in the peripheral vasculature - a review of the current literature","volume":"5","author":"Linn","year":"2022","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.jcin.2024.03.029_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1526602820941811","article-title":"Six-month outcomes from the first-in-human, single-arm SELUTION sustained-limus-release drug-eluting balloon trial in femoropopliteal lesions","volume":"27","author":"Zeller","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.03.029_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/15266028211007457","article-title":"World's first experience treating TASC II C and D tibial occlusive disease using the Selution SLR sirolimus-eluting balloon: six-month results from the PRESTIGE study","volume":"28","author":"Tang","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.03.029_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/15266028211064816","article-title":"MagicTouch PTA sirolimus coated balloon for femoropopliteal and below the knee disease: results from XTOSI pilot study up to 12 months","volume":"29","author":"Choke","year":"2022","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.03.029_bib13","first-page":"355","article-title":"The COMPLIANCE 360 degrees trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease","volume":"26","author":"Dattilo","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jcin.2024.03.029_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fca-2020-0085","article-title":"The SELUTION SLR drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions","volume":"17","author":"Bohme","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jcin.2024.03.029_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"issue":"10415","key":"10.1016\/j.jcin.2024.03.029_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jcin.2024.03.029_bib17","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jcin.2023.08.028","article-title":"Early and late ruptured aneurysm after endovascular therapy with paclitaxel-coated balloon","volume":"16","author":"Takimura","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.029_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jvs.2014.03.291","article-title":"Paclitaxel-coated balloons and aneurysm formation in peripheral vessels","volume":"62","author":"Diamantopoulos","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcin.2024.03.029_bib19","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jvir.2016.06.036","article-title":"Comparison of particulate embolization after femoral artery treatment with IN.PACT Admiral versus Lutonix 035 paclitaxel-coated balloons in healthy swine","volume":"27","author":"Kolodgie","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jcin.2024.03.029_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.03.029_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00380-021-01947-3","article-title":"One-year results for Japanese patients in RANGER II SFA","volume":"37","author":"Soga","year":"2022","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jcin.2024.03.029_bib22","first-page":"1100","article-title":"Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery","volume":"100","author":"Iida","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.03.029_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025677","article-title":"Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion","volume":"12","author":"Soga","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jcin.2024.03.029_bib24","doi-asserted-by":"crossref","first-page":"E784","DOI":"10.25270\/jic\/22.00149","article-title":"Superficial femoral artery endovascular therapy: 12-month primary patency rates of contemporary endovascular devices from 25,051 patients","volume":"34","author":"Marmagkiolis","year":"2022","journal-title":"J Invasive Cardiol"},{"issue":"8","key":"10.1016\/j.jcin.2024.03.029_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","article-title":"Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study","volume":"7","author":"McKinsey","year":"2014","journal-title":"JACC Cardiovasc Interv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824006332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824006332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:03:07Z","timestamp":1783368187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824006332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":25,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1936879824006332"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2024.03.029","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2024.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}